Interrogating the druggable genome with structural informatics
- 119 Downloads
Structural genomics projects are producing protein structure data at an unprecedented rate. In this paper, we present the Target Informatics Platform (TIP), a novel structural informatics approach for amplifying the rapidly expanding body of experimental protein structure information to enhance the discovery and optimization of small molecule protein modulators on a genomic scale. In TIP, existing experimental structure information is augmented using a homology modeling approach, and binding sites across multiple target families are compared using a clique detection algorithm. We report here a detailed analysis of the structural coverage for the set of druggable human targets, highlighting drug target families where the level of structural knowledge is currently quite high, as well as those areas where structural knowledge is sparse. Furthermore, we demonstrate the utility of TIP's intra- and inter-family binding site similarity analysis using a series of retrospective case studies. Our analysis underscores the utility of a structural informatics infrastructure for extracting drug discovery-relevant information from structural data, aiding researchers in the identification of lead discovery and optimization opportunities as well as potential “off-target” liabilities.
Keywordsstructure–based drug design druggable genome protein structures ligand binding sites drug targets structural genomics
Unable to display preview. Download preview PDF.
- 14.Debe, D.A., Danzer, J.F., Goddard, W.A. 3rd and Poleksic, A., STRUCTFAST: Extreme remote homology detection and alignment using novel dynamic programming and profile-profile scoring, Proteins, submitted.Google Scholar
- 15.Xie, L., Danzer, J.F. and Debe, D.A., publication in progress.Google Scholar
- 16.Xie, L., Danzer, J.F. and Debe, D.A., publication in progress.Google Scholar
- 18.Palmer, B., Danzer, J.F., Hambly, K. and Debe, D.A., StructSorter: A continuously maintained pair-wise structure alignment of a comprehensive protein structure database, Bioinformatics, submitted.Google Scholar
- 28.Bernardo, A., Ajmone-Cat, M.A., Gasparini, L., Ongini, E. and Minghetti, L., Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen, J. Neurochem., 92 (2005) 895–903.PubMedCrossRefGoogle Scholar
- 29.Tanaka, K., Kubushiro, K., Iwamori, Y., Okairi, Y., Kiguchi, K., Ishiwata, I., Tsukazaki, K., Nozawa, S., Iwamori, M., Estrogen sulfotransferase and sulfatase: Roles in the regulation of estrogen activity in human uterine endometrial carcinomas, Cancer Sci., 94 (2003) 871–876.PubMedCrossRefGoogle Scholar
- 30.European Medicines Agency; Summary of Product Characteristics — Etoricoxib. http://www.emea.eu.int/pdfs/human/epar/Etoricoxib.pdf.